Back to news

CorVel Announces Revenues and Earnings

Globe Newswire•03/11/2026•06:15 ET
4

Key Highlights

  • ➤Q2 revenue increased 11% to $267 million year over year
  • ➤Diluted EPS increased 24% to $0.67 year over year
  • ➤Gross profit increased 24% to $72.3 million, with 27% gross margin
  • ➤CorVel exited the quarter with $270 million cash and no borrowings
  • ➤CorVel repurchased $18.1 million of common stock during the quarter

FORT WORTH, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended September 30, 2026. Revenues for the quarter were $267 million, an increase from $240 million in the September quarter of 2025. Earnings per share for the quarter were $0.67, compared to $0.54 in the same quarter of the prior year. Revenues for the six months ended September 30, 2026 were $527 million, an increase from $474 million for the six months ended September 30, 2025. Earnings per share for the six months ended September 30, 2026 were $1.31, compared to $1.06 during the six months ended September 30, 2025.

Second Quarter Fiscal Year 2027 Highlights * Revenue increased 11% to $267 million, compared to the second quarter of fiscal year 2026. * Gross profit increased 24% to $72.3 million, at a 27% gross margin, compared to the second quarter of fiscal year 2026 gross profit of $58.2 million. * Diluted earnings per share increased 24% to $0.67, compared to second quarter of fiscal year 2026 diluted earnings per share of $0.54. * The Company exited the quarter with $270 million of cash, cash equivalents, and no borrowings. * The Company repurchased $18.1 million of common stock during the quarter. CorVel generated strong momentum in its workers' compensation and liability businesses through new customer wins and deeper relationships with existing clients. As employers and insurers face greater claim complexity, rising medical costs, and increasing administrative demands, the Company's integrated claims management and managed care model brings together clinical expertise, technology, and cost containment solutions to improve patient outcomes and manage total claim costs.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in